Kanagawa, Japan

Yosuke Yamamoto

USPTO Granted Patents = 29 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Kanagawa, JP (2012 - 2021)
  • Ashigarakami-gun, JP (2021)
  • Minamiashigara, JP (2021 - 2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
29 patents (USPTO):

Title: Yosuke Yamamoto: A Pioneer in Peptide Production and Cell Adhesion Technology

Introduction: Yosuke Yamamoto, based in Kanagawa, Japan, is a distinguished innovator with a remarkable portfolio of 25 patents. His contributions to the fields of peptide compounds and cell adhesion mechanisms showcase his expertise in biotechnology and materials science.

Latest Patents: Yamamoto's latest inventions include a method for producing peptide compounds that integrates a protective group-forming reagent. This innovative method details a process utilizing a compound represented by Formula (1), where specific aliphatic hydrocarbon groups are crucial. Notably, these groups consist of 12 or more carbon atoms, excluding silyl groups and structures with silyloxy. Additionally, he has developed a cell adhesion sheet designed to suppress platelet adhesion while enhancing cellular adhesion, reflecting his commitment to advancing medical technologies.

Career Highlights: Throughout his career, Yosuke Yamamoto has made significant strides in biotechnology while working at notable companies such as Fujifilm Corporation and UDC Ireland Limited. His experience in these industry leaders facilitated the application of his research and innovations on a global scale.

Collaborations: Yamamoto has collaborated with prominent colleagues, notably Kousuke Watanabe and Saki Takada. These partnerships exemplify the collaborative effort often vital in driving innovation and achieving breakthrough results in science and technology.

Conclusion: Yosuke Yamamoto's contributions to the fields of peptide production and cell adhesion technology position him as a leading inventor of his time. With a robust portfolio of patents and a collaborative spirit, his work continues to influence advancements in biotechnology, which may result in significant implications for medical science and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…